Moreover, NSCLC cells were treated with CsA, the CypA inhibitor, in combination with chemotherapeutics enhanced the efficacy of DDP and DTX in NSCLC cells (Figure 6E; Figure S4A‐C, Supporting Information). Here, PPIA is linked to non-small cell lung carcinoma.